comparemela.com

Latest Breaking News On - Charles bankhead - Page 7 : comparemela.com

FDA OKs Second Gene Therapy for Hemophilia B

One dose of fidanacogene elaparvovec proved noninferior to standard prophylactic factor IX

United statesUniversity of pennsylvaniaAdam cukerCharles bankheadHemophilia thrombosis programPenn comprehensiveMedpage today

Clue to Aspirin, Colon Cancer Link; New Lutathera Approval; AI & Electronic Records

News, features, and commentary about cancer-related issues

United statesAndrew smithCharles bankheadLancet digital healthAmerican society of clinical oncologyUniversity of texas md anderson cancer centerCollege of american pathologistsUniversity health systemGilead sciencesJude children research hospitalAmerican societyClinical oncologyAmerican pathologistsCancer centerJude childrenResearch hospital

ESR1-Driven Resistance to CDK4/6 Inhibitors in Breast Cancer Thwarted by SERDs

Time to next treatment reduced in mutant tumors with CDK4/6 inhibitor plus aromatase inhibitor

United statesWilliamj gradisharPatricia robinsonCharles bankheadHarvard medical schoolHospital cancer centerMassachusetts general hospital cancer centerComprehensive cancer centerNorthwestern universityMedpage today

High Deep-Remission Rate With Triple Regimen for Relapsed/Refractory CLL

Undetectable disease rate over 90%, ctDNA also promising for earlier detection of recurrence

United statesCharles bankheadRichard larsonUniversity of chicagoUniversity of cologneAmerican society of hematologyAmerican societyMedpage today

Brachytherapy for Prostate Cancer Linked to Higher Risk of Second Pelvic Malignancy

Risk for any second malignancy, death from any second malignancy not higher versus prostatectomy

United kingdomBritish columbiaCharles bankheadScott tyldesleySiteman cancer centerBc cancer agencyAmerican society for radiation oncologyWashington university in stLannis hallWashington universityMedpage todayAmerican societyRadiation oncology

vimarsana © 2020. All Rights Reserved.